|
Real-time Estimate
Cboe BZX
13:47:28 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 16.95 USD | +3.67% |
|
-4.87% | -44.24% |
| 10-12 | Jefferies & Co Initiates Coverage on Beta Bionics With Buy Rating, $30 Price Target | MT |
| 10-07 | Barclays Initiates Beta Bionics at Overweight With $30 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 861M | - | ||||
| 255B | |||||
| 161B | |||||
| 151B | |||||
| 64.33B | |||||
| 51.9B |
- Stock Market
- Stocks
- BBNX Stock
- Charts Beta Bionics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
